参考文献（下滑查看）：

[1]Klok FA , van der Hulle T , den Exter PL ,et al. The post-PE syndrome: a new concept for chronic complications of pulmonary embolism[J]. Blood Rev, 2014,28(6):221-226. DOI: 10.1016/j.blre.2014.07.003 .

[2]Humbert M , Kovacs G , Hoeper MM ,et al. 2022 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension[J]. Eur Heart J, 2022,43(38):3618-3731. DOI: 10.1093/eurheartj/ehac237 .

[3]中华医学会呼吸病学分会肺栓塞与肺血管病学组,中国医师协会呼吸医师分会肺栓塞与肺血管病工作委员会,全国肺栓塞与肺血管病防治协作组. 肺血栓栓塞症诊治与预防指南[J]. 中华医学杂志, 2018,98(14):1060-1087. DOI: 10.3760/cma.j.issn.0376-2491.2018.14.007 .

[4]Guyatt G , Oxman AD , Akl EA ,et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables[J]. J Clin Epidemiol, 2011,64(4):383-394. DOI: 10.1016/j.jclinepi.2010.04.026 .

[5]World Health Organization. WHO handbook for guideline development[EB/OL].[ 2025-01-01]. https://www.who.int/publications/i/item/9789241548960

[6]陈耀龙,杨克虎,王小钦,等. 中国制订/修订临床诊疗指南的指导原则(2022版)[J]. 中华医学杂志, 2022, (10). DOI: 10.3760/cma.j.cn112137-20211228-02911 .

[7]Song Y , Alonso-Coello P , Ballesteros M ,et al. A reporting tool for adapted guidelines in health care: the RIGHT-Ad@pt Checklist[J]. Ann Intern Med, 2022,175(5):710-719. DOI: 10.7326/M21-4352 .

[8]Shea BJ , Grimshaw JM , Wells GA ,et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews[J]. BMC Med Res Methodol, 2007,7:10. DOI: 10.1186/1471-2288-7-10 .

[9]Higgins JP , Altman DG , Gøtzsche PC ,et al. The Cochrane Collaboration′s tool for assessing risk of bias in randomised trials[J]. BMJ, 2011,343:d5928. DOI: 10.1136/bmj.d5928 .

[10]Whiting PF , Rutjes AW , Westwood ME ,et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies[J]. Ann Intern Med, 2011,155(8):529-536. DOI: 10.7326/0003-4819-155-8-201110180-00009 .

[11]Wells GA , Shea B , O′Connell D ,et al. The Newcastle Ottawa Scale (NOS) for assessing the quality of nonrandomized studies in meta-analyses[EB/OL].[ 2025-04-04]. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp

[12]Vernooij RW , Sanabria AJ , Solà I ,et al. Guidance for updating clinical practice guidelines: a systematic review of methodological handbooks[J]. Implement Sci, 2014,9:3. DOI: 10.1186/1748-5908-9-3 .

[13]Wendelboe AM , Raskob GE . Global burden of thrombosis: epidemiologic aspects[J]. Circ Res, 2016,118(9):1340-1347. DOI: 10.1161/CIRCRESAHA.115.306841 .

[14]Correction to: 2024 Heart Disease and Stroke Statistics: a report of US and Global Data from the American Heart Association[J]. Circulation, 2024,149(19):e1164. DOI: 10.1161/CIR.0000000000001247 .

[15]Law Y , Chan YC , Cheng S . Epidemiological updates of venous thromboembolism in a Chinese population[J]. Asian J Surg, 2018,41(2):176-182. DOI: 10.1016/j.asjsur.2016.11.005 .

[16]Martin SS , Aday AW , Allen NB ,et al. 2025 heart disease and stroke statistics: a report of US and global data from the American Heart Association[J]. Circulation, 2025,151(8):e41-e660. DOI: 10.1161/CIR.0000000000001303 .

[17]Benjamin EJ , Virani SS , Callaway CW ,et al. Heart disease and stroke statistics-2018 update: a report from the American Heart Association[J]. Circulation, 2018,137(12):e67-e492. DOI: 10.1161/CIR.0000000000000558 .

[18]Tsao CW , Aday AW , Almarzooq ZI ,et al. Heart disease and stroke statistics-2022 update: a report from the American Heart Association[J]. Circulation, 2022,145(8):e153-e639. DOI: 10.1161/CIR.0000000000001052 .

[19]Zhang Z , Lei J , Shao X ,et al. Trends in hospitalization and in-hospital mortality from VTE, 2007 to 2016, in China[J]. Chest, 2019,155(2):342-353. DOI: 10.1016/j.chest.2018.10.040 .

[20]Zhen K , Tao Y , Xia L ,et al. Epidemiology of pulmonary embolism in China, 2021: a nationwide hospital-based study[J]. Lancet Reg Health West Pac, 2025,54:101258. DOI: 10.1016/j.lanwpc.2024.101258 .

[21]Barco S , Mahmoudpour SH , Valerio L ,et al. Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database[J]. Lancet Respir Med, 2020,8(3):277-287. DOI: 10.1016/S2213-2600(19)30354-6 .

[22]Barco S , Valerio L , Ageno W ,et al. Age-sex specific pulmonary embolism-related mortality in the USA and Canada, 2000-18: an analysis of the WHO Mortality Database and of the CDC Multiple Cause of Death database[J]. Lancet Respir Med, 2021,9(1):33-42. DOI: 10.1016/S2213-2600(20)30417-3 .

[23]Kobayashi T , Pugliese S , Sethi SS ,et al. Contemporary management and outcomes of patients with high-risk pulmonary embolism[J]. J Am Coll Cardiol, 2024,83(1):35-43. DOI: 10.1016/j.jacc.2023.10.026 .

[24]Zuin M , Bikdeli B , Davies J ,et al. Contemporary trends in mortality related to high- risk pulmonary embolism in US from 1999 to 2019 [J]. Thromb Res, 2023,228:72-80. DOI: 10.1016/j.thromres.2023.05.028 .

[25]Jaureguízar A , Jiménez D , Bikdeli B ,et al. Heart rate and mortality in patients with acute symptomatic pulmonary embolism[J]. Chest, 2022,161(2):524-534. DOI: 10.1016/j.chest.2021.08.059 .

[26]Jiménez D , Bikdeli B , Barrios D ,et al. Epidemiology, patterns of care and mortality for patients with hemodynamically unstable acute symptomatic pulmonary embolism[J]. Int J Cardiol, 2018,269:327-333. DOI: 10.1016/j.ijcard.2018.07.059 .

[27]Zhai Z , Wang D , Lei J ,et al. Trends in risk stratification, in-hospital management and mortality of patients with acute pulmonary embolism: an analysis from the China pUlmonary thromboembolism REgistry Study (CURES)[J]. Eur Respir J, 2021,58(4):2002963[pii]. DOI: 10.1183/13993003.02963-2020 .

[28]Guérin L , Couturaud F , Parent F ,et al. Prevalence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism. Prevalence of CTEPH after pulmonary embolism[J]. Thromb Haemost, 2014,112(3):598-605. DOI: 10.1160/TH13-07-0538 .

[29]Simonneau G , Hoeper MM . Evaluation of the incidence of rare diseases: difficulties and uncertainties, the example of chronic thromboembolic pulmonary hypertension[J]. Eur Respir J, 2017,49(2):1602522[pii]. DOI: 10.1183/13993003.02522-2016 .

[30]Ende-Verhaar YM , Cannegieter SC , Vonk Noordegraaf A ,et al. Incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: a contemporary view of the published literature[J]. Eur Respir J, 2017,49(2):1601792[pii]. DOI: 10.1183/13993003.01792-2016 .

[31]Pang W , Zhang Z , Wang Z ,et al. Higher incidence of chronic thromboembolic pulmonary hypertension after acute pulmonary embolism in Asians than in Europeans: a meta-analysis[J]. Front Med (Lausanne), 2021,8:721294. DOI: 10.3389/fmed.2021.721294 .

[32]Xie W , Yu Y , Huang Q ,et al. Epidemiology and management patterns of chronic thromboembolic pulmonary hypertension in China[J]. Chin Med J (Engl), 2025,138(8):1000-1002. DOI: 10.1097/CM9.0000000000003580 .

[33]Bagot CN , Arya R . Virchow and his triad: a question of attribution[J]. Br J Haematol, 2008,143(2):180-190. DOI: 10.1111/j.1365-2141.2008.07323.x .

[34]Moran J , Bauer KA . Managing thromboembolic risk in patients with hereditary and acquired thrombophilias[J]. Blood, 2020,135(5):344-350. DOI: 10.1182/blood.2019000917 .

[35]Zhang Y , Zhang Z , Shu S ,et al. The genetics of venous thromboembolism: a systematic review of thrombophilia families[J]. J Thromb Thrombolysis, 2021,51(2):359-369. DOI: 10.1007/s11239-020-02203-7 .

[36]Anderson FA Jr, Spencer FA . Risk factors for venous thromboembolism[J]. Circulation, 2003,107(23Suppl 1):I9-16. DOI: 10.1161/01.CIR.0000078469.07362.E6 .

[37]Timp JF , Braekkan SK , Versteeg HH ,et al. Epidemiology of cancer-associated venous thrombosis[J]. Blood, 2013,122(10):1712-1723. DOI: 10.1182/blood-2013-04-460121 .

[38]Hemon F , Fouchard F , Tromeur C ,et al. Association between hospitalization for acute medical illness and VTE risk: a lower efficacy of thromboprophylaxis in elderly patients? Results from the EDITH case-control study[J]. Eur J Intern Med, 2017,44:39-43. DOI: 10.1016/j.ejim.2017.05.029 .

[39]Lidegaard Ø , Nielsen LH , Skovlund CW ,et al. Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: danish cohort study, 2001-9[J]. BMJ, 2011,343:d6423. DOI: 10.1136/bmj.d6423 .

[40]Zöller B , Li X , Sundquist J ,et al. Age-and gender-specific familial risks for venous thromboembolism: a nationwide epidemiological study based on hospitalizations in Sweden[J]. Circulation, 2011,124(9):1012-1020. DOI: 10.1161/CIRCULATIONAHA.110.965020 .

[41]Ospina-Romero M , Cannegieter SC , den Heijer M ,et al. Hyperhomocysteinemia and risk of first venous thrombosis: the influence of (unmeasured) confounding factors[J]. Am J Epidemiol, 2018,187(7):1392-1400. DOI: 10.1093/aje/kwy004 .

[42]Zöller B , Li X , Sundquist J ,et al. Autoimmune diseases and venous thromboembolism: a review of the literature[J]. Am J Cardiovasc Dis, 2012,2(3):171-183.

[43]Prandoni P , Barbar S , Milan M ,et al. The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: new scenarios and opportunities[J]. Eur J Intern Med, 2014,25(1):25-30. DOI: 10.1016/j.ejim.2013.09.005 .

[44]Konstantinides SV , Meyer G , Becattini C ,et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)[J]. Eur Heart J, 2020,41(4):543-603. DOI: 10.1093/eurheartj/ehz405 .

[45]Lyhne MD , Schultz JG , Kramer A ,et al. Right ventricular adaptation in the critical phase after acute intermediate-risk pulmonary embolism[J]. Eur Heart J Acute Cardiovasc Care, 2021,10(3):243-249. DOI: 10.1177/2048872620925253 .

[46]Alerhand S , Adrian RJ . What echocardiographic findings differentiate acute pulmonary embolism and chronic pulmonary hypertension?[J]. Am J Emerg Med, 2023,72:72-84. DOI: 10.1016/j.ajem.2023.07.011 .

[47]Watts JA , Marchick MR , Kline JA . Right ventricular heart failure from pulmonary embolism: key distinctions from chronic pulmonary hypertension[J]. J Card Fail, 2010,16(3):250-259. DOI: 10.1016/j.cardfail.2009.11.008 .

[48]Kim NH , D′Armini AM , Delcroix M ,et al. Chronic thromboembolic pulmonary disease[J]. Eur Respir J, 2024,64(4):2401294. DOI: 10.1183/13993003.01294-2024 .

[49]Yang J , Xu J , Xu S ,et al. Oxidative stress in acute pulmonary embolism: emerging roles and therapeutic implications[J]. Thromb J, 2024,22(1):9. DOI: 10.1186/s12959-023-00577-1 .

[50]Lu G , Jia Z , Zu Q ,et al. Inhibition of the cyclophilin A-CD147 interaction attenuates right ventricular injury and dysfunction after acute pulmonary embolism in rats[J]. J Biol Chem, 2018,293(31):12199-12208. DOI: 10.1074/jbc.RA118.002845 .

[51]Rezania S , Puskarich MA , Petrusca DN ,et al. Platelet hyperactivation, apoptosis and hypercoagulability in patients with acute pulmonary embolism[J]. Thromb Res, 2017,155:106-115. DOI: 10.1016/j.thromres.2017.05.009 .

[52]Delcroix M , Torbicki A , Gopalan D ,et al. ERS statement on chronic thromboembolic pulmonary hypertension[J]. Eur Respir J, 2021,57(6):2002828[pii]. DOI: 10.1183/13993003.02828-2020 .

[53]Quarck R , Wynants M , Verbeken E ,et al. Contribution of inflammation and impaired angiogenesis to the pathobiology of chronic thromboembolic pulmonary hypertension[J]. Eur Respir J, 2015,46(2):431-443. DOI: 10.1183/09031936.00009914 .

[54]Kaptein F , Kroft L , Hammerschlag G ,et al. Pulmonary infarction in acute pulmonary embolism[J]. Thromb Res, 2021,202:162-169. DOI: 10.1016/j.thromres.2021.03.022 .

[55]Tian H , Zhang Y , Liu J ,et al. Sex disparities of clinical manifestations in acute pulmonary embolism and predictive value for in-hospital mortality: insights from CURES[J]. Thromb Res, 2024,243:109146. DOI: 10.1016/j.thromres.2024.109146 .

[56]Reynen E , Severn M . Point-of-care d-dimer testing: a review of diagnostic accuracy, clinical utility, and safety[Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health, 2017.

[57]Konstantinides S , Geibel A , Olschewski M ,et al. Importance of cardiac troponins I and T in risk stratification of patients with acute pulmonary embolism[J]. Circulation, 2002,106(10):1263-1268. DOI: 10.1161/01.cir.0000028422.51668.a2 .

[58]Bajaj A , Saleeb M , Rathor P ,et al. Prognostic value of troponins in acute nonmassive pulmonary embolism: a me ta-analysis [J]. Heart Lung, 2015,44(4):327-334. DOI: 10.1016/j.hrtlng.2015.03.007 .

[59]Mueller C , McDonald K , de Boer R A ,et al. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations[J]. Eur J Heart Fail, 2019,21(6):715-731. DOI: 10.1002/ejhf.1494 .

[60]Henzler T , Roeger S , Meyer M ,et al. Pulmonary embolism: CT signs and cardiac biomarkers for predicting right ventricular dysfunction[J]. Eur Respir J, 2012,39(4):919-926. 10.1183/09031936.00088711 .

[61]Klok FA , Mos IC , Huisman MV . Brain-type natriuretic peptide levels in the prediction of adverse outcome in patients with pulmonary embolism: a systematic review and meta-analysis[J]. Am J Respir Crit Care Med, 2008,178(4):425-430. DOI: 10.1164/rccm.200803-459OC .

[62]Goetze JP , Bruneau BG , Ramos HR ,et al. Cardiac natriuretic peptides[J]. Nat Rev Cardiol, 2020,17(11):698-717. DOI: 10.1038/s41569-020-0381-0 .

[63]Bayes-Genis A , Docherty KF , Petrie MC ,et al. Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: a clinical consensus statement from the Heart Failure Association of the ESC[J]. Eur J Heart Fail, 2023,25(11):1891-1898. DOI: 10.1002/ejhf.3036 .

[64]Vanni S , Viviani G , Baioni M ,et al. Prognostic value of plasma lactate levels among patients with acute pulmonary embolism: the thrombo-embolism lactate outcome study[J]. Ann Emerg Med, 2013,61(3):330-338. DOI: 10.1016/j.annemergmed.2012.10.022 .

[65]Kostrubiec M , Pływaczewska M , Jiménez D ,et al. The prognostic value of renal function in acute pulmonary embolism-a multi-centre cohort study[J]. Thromb Haemost, 2019,119(1):140-148. DOI: 10.1055/s-0038-1676522 .

[66]Kostrubiec M , Łabyk A , Pedowska-Włoszek J ,et al. Neutrophil gelatinase-associated lipocalin, cystatin C and eGFR indicate acute kidney injury and predict prognosis of patients with acute pulmonary embolism[J]. Heart, 2012,98(16):1221-1228. DOI: 10.1136/heartjnl-2012-301884 .

[67]Hellenkamp K , Pruszczyk P , Jiménez D ,et al. Prognostic impact of copeptin in pulmonary embolism: a multicentre validation study[J]. Eur Respir J, 2018,51(4):1702037[pii]. DOI: 10.1183/13993003.02037-2017 .

[68]Zhou XY , Chen HL , Ni SS . Hyponatremia and short-term prognosis of patients with acute pulmonary embolism: a meta-analysis[J]. Int J Cardiol, 2017,227:251-256. DOI: 10.1016/j.ijcard.2016.11.120 .

[69]Shopp JD , Stewart LK , Emmett TW ,et al. Findings from 12-lead electrocardiography that predict circulatory shock from pulmonary embolism: systematic review and meta-analysis[J]. Acad Emerg Med, 2015,22(10):1127-1137. DOI: 10.1111/acem.12769 .

[70]Elliott CG , Goldhaber SZ , Visani L ,et al. Chest radiographs in acute pulmonary embolism. Results from the International Cooperative Pulmonary Embolism Registry[J]. Chest, 2000,118(1):33-38. DOI: 10.1378/chest.118.1.33 .

[71]Kearon C , Ginsberg JS , Hirsh J . The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism[J]. Ann Intern Med, 1998,129(12):1044-1049. DOI: 10.7326/0003-4819-129-12-199812150-00009 .

[72]Le Gal G , Righini M , Sanchez O ,et al. A positive compression ultrasonography of the lower limb veins is highly predictive of pulmonary embolism on computed tomography in suspected patients[J]. Thromb Haemost, 2006,95(6):963-966. DOI: 10.1160/TH06-03-0158 .

[73]Da Costa Rodrigues J , Alzuphar S , Combescure C ,et al. Diagnostic characteristics of lower limb venous compression ultrasonography in suspected pulmonary embolism: a meta-analysis[J]. J Thromb Haemost, 2016,14(9):1765-1772. DOI: 10.1111/jth.13407 .

[74]Kurnicka K , Lichodziejewska B , Goliszek S ,et al. Echocardiographic pattern of acute pulmonary embolism: analysis of 511 consecutive patients[J]. J Am Soc Echocardiogr, 2016,29(9):907-913. DOI: 10.1016/j.echo.2016.05.016 .

[75]Torbicki A , Galié N , Covezzoli A ,et al. Right heart thrombi in pulmonary embolism: results from the International Cooperative Pulmonary Embolism Registry[J]. J Am Coll Cardiol, 2003,41(12):2245-2251. DOI: 10.1016/s0735-1097(3)00479-0 .

[76]Koć M , Kostrubiec M , Elikowski W ,et al. Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry[J]. Eur Respir J, 2016,47(3):869-875. DOI: 10.1183/13993003.00819-2015 .

[77]Barrios D , Rosa-Salazar V , Jiménez D ,et al. Right heart thrombi in pulmonary embolism[J]. Eur Respir J, 2016,48(5):1377-1385. DOI: 10.1183/13993003.01044-2016 .

[78]Soffer S , Klang E , Shimon O ,et al. Deep learning for pulmonary embolism detection on computed tomography pulmonary angiogram: a systematic review and meta-analysis[J]. Sci Rep, 2021,11(1):15814. DOI: 10.1038/s41598-021-95249-3 .

[79]Reichert M , Henzler T , Krissak R ,et al. Venous thromboembolism: additional diagnostic value and radiation dose of pelvic CT venography in patients with suspected pulmonary embolism[J]. Eur J Radiol, 2011,80(1):50-53. DOI: 10.1016/j.ejrad.2010.12.101 .

[80]Weidman EK , Plodkowski AJ , Halpenny DF ,et al. Dual-energy CT angiography for detection of pulmonary emboli: incremental benefit of iodine maps[J]. Radiology, 2018,289(2):546-553. DOI: 10.1148/radiol.2018180594 .

[81]Squizzato A , Venturini A , Pelitti V ,et al. Diagnostic accuracy of V/Q and Q SPECT/CT in patients with suspected acute pulmonary embolism: a systematic review and meta-analysis[J]. Thromb Haemost, 2023,123(7):700-713. DOI: 10.1055/a-1986-8878 .

[82]Bajc M , Schümichen C , Grüning T ,et al. EANM guideline for ventilation/perfusion single-photon emission computed tomography (SPECT) for diagnosis of pulmonary embolism and beyond [J]. Eur J Nucl Med Mol Imaging, 2019,46(12):2429-2451. DOI: 10.1007/s00259-019-04450-0 .

[83]Mortensen J , Gutte H . SPECT/CT and pulmonary embolism[J]. Eur J Nucl Med Mol Imaging, 2014,41(Suppl 1):S81-S90. DOI: 10.1007/s00259-013-2614-5 .

[84]Silva RF , Zanon M , Ackman JB ,et al. Comparison of the diagnostic performance of non-contrast MR angiography and planar V/Q scintigraphy for pulmonary embolism: a systematic review and meta-analysis[J]. Eur Radiol, 2025. DOI: 10.1007/s00330-025-11366-x .

[85]Hansch A , Betge S , Poehlmann G ,et al. Combined magnetic resonance imaging of deep venous thrombosis and pulmonary arteries after a single injection of a blood pool contrast agent[J]. Eur Radiol, 2011,21(2):318-325. DOI: 10.1007/s00330-010-1918-0 .

[86]Stein PD , Henry JW , Gottschalk A . Reassessment of pulmonary angiography for the diagnosis of pulmonary embolism: relation of interpreter agreement to the order of the involved pulmonary arterial branch[J]. Radiology, 1999,210(3):689-691. DOI: 10.1148/radiology.210.3.r99mr41689 .

[87]Diffin DC , Leyendecker JR , Johnson SP ,et al. Effect of anatomic distribution of pulmonary emboli on interobserver agreement in the interpretation of pulmonary angiography[J]. AJR Am J Roentgenol, 1998,171(4):1085-1089. DOI: 10.2214/ajr.171.4.9763002 .

[88]Stein PD , Athanasoulis C , Alavi A ,et al. Complications and validity of pulmonary angiography in acute pulmonary embolism[J]. Circulation, 1992,85(2):462-468. DOI: 10.1161/01.cir.85.2.462 .

[89]Engelberger RP , Kucher N . Catheter-based reperfusion treatment of pulmonary embolism[J]. Circulation, 2011,124(19):2139-2144. DOI: 10.1161/CIRCULATIONAHA.111.023689 .

[90]Penaloza A , Verschuren F , Meyer G ,et al. Comparison of the unstructured clinician gestalt, the wells score, and the revised Geneva score to estimate pretest probability for suspected pulmonary embolism[J]. Ann Emerg Med, 2013,62(2):117-124.e2. DOI: 10.1016/j.annemergmed.2012.11.002 .

[91]Gibson NS , Sohne M , Kruip MJ ,et al. Further validation and simplification of the Wells clinical decision rule in pulmonary embolism[J]. Thromb Haemost, 2008,99(1):229-234. DOI: 10.1160/TH07-05-0321 .

[92]van der Hulle T , Cheung WY , Kooij S ,et al. Simplified diagnostic management of suspected pulmonary embolism (the YEARS study): a prospective, multicentre, cohort study[J]. Lancet, 2017,390(10091):289-297. DOI: 10.1016/S0140-6736(17)30885-1 .

[93]Penaloza A , Soulié C , Moumneh T ,et al. Pulmonary embolism rule-out criteria (PERC) ru le in European patients with low implicit clinical probability (PERCEPIC): a multicentre, prospective, observational study [J]. Lancet Haematol, 2017,4(12):e615-e621. DOI: 10.1016/S2352-3026(17)30210-7 .

[94]Lyu Y , Li H , Liu X ,et al. Estimated glomerular filtration rate decline is causally associated with acute pulmonary embolism: a nested case-control and mendelian randomization study[J]. Thromb Haemost, 2025. DOI: 10.1055/a-2439-5200 .

[95]Dicks AB , Moussallem E , Stanbro M ,et al. A comprehensive review of risk factors and thrombophilia evaluation in venous thromboembolism[J]. J Clin Med, 2024,13(2):362. DOI: 10.3390/jcm13020362 .

[96]Devreese K , Bertolaccini ML , Branch DW ,et al. An update on laboratory detection and interpretation of antiphospholipid antibodies for diagnosis of antiphospholipid syndrome: guidance from the ISTH-SSC Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibodies[J]. J Thromb Haemost, 2025,23(2):731-744. DOI: 10.1016/j.jtha.2024.10.022 .

[97]Van Cott EM , Orlando C , Moore GW ,et al. Recommendations for clinical laboratory testing for antithrombin deficiency; communication from the SSC of the ISTH[J]. J Thromb Haemost, 2020,18(1):17-22. DOI: 10.1111/jth.14648 .

[98]Cooper PC , Pavlova A , Moore GW ,et al. Recommendations for clinical laboratory testing for protein C deficiency, for the subcommittee on plasma coagulation inhibitors of the ISTH[J]. J Thromb Haemost, 2020,18(2):271-277. DOI: 10.1111/jth.14667 .

[99]Colucci G , Tsakiris DA . Thrombophilia screening revisited: an issue of personalized medicine[J]. J Thromb Thrombolysis, 2020,49(4):618-629. DOI: 10.1007/s11239-020-02090-y .

[100]Darlow J , Mould H . Thrombophilia testing in the era of direct oral anticoagulants[J]. Clin Med (Lond), 2021,21(5):e487-e491. DOI: 10.7861/clinmed.2020-1008 .

[101]Zhang Z , Li H , Weng H ,et al. Genome-wide association analyses identified novel susceptibility loci for pulmonary embolism among Han Chinese population[J]. BMC Med, 2023,21(1):153. DOI: 10.1186/s12916-023-02844-4 .

[102]Suchon P , Soukarieh O , Bernard C ,et al. Assessment of a next generation sequencing gene panel strategy in 133 patients with negative thrombophilia screening[J]. J Thromb Haemost, 2025,23(3):997-1008. DOI: 10.1016/j.jtha.2024.12.006 .

[103]Matthews TM , Peters GA , Wang G ,et al. Optimal cutoff values and utility of high-sensitivity troponin T and NT-proBNP for the risk stratification of patients with acute pulmonary embolism[J]. Clin Chem, 2025,71(5):559-566. DOI: 10.1093/clinchem/hvae212 .

[104]Lankeit M , Jiménez D , Kostrubiec M ,et al. Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study [J]. Circulation, 2011,124(24):2716-2724. DOI: 10.1161/CIRCULATIONAHA.111.051177 .

[105]Lankeit M , Jiménez D , Kostrubiec M ,et al. Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism[J]. Eur Respir J, 2014,43(6):1669-1677. DOI: 10.1183/09031936.00211613 .

[106]Nishikawa R , Yamashita Y , Morimoto T ,et al. Selection of home treatment and identification of low-risk patients with pulmonary embolism based on simplified pulmonary embolism severity index score in the era of direct oral anticoagulants [J]. J Am Heart Assoc, 2024,13(19):e034953. DOI: 10.1161/JAHA.124.034953 .

[107]Roy PM , Penaloza A , Hugli O ,et al. Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial[J]. Eur Heart J, 2021,42(33):3146-3157. DOI: 10.1093/eurheartj/ehab373 .

[108]Zhang Y , Chen Y , Chen H ,et al. Performance of the simplified pulmonary embolism severity index in predicting 30-day mortality after acute pulmonary embolism: validation from a large-scale cohort[J]. Eur J Intern Med, 2024,124:46-53. DOI: 10.1016/j.ejim.2024.01.037 .

[109]McGuire WC , Sullivan L , Odish MF ,et al. Management strategies for acute pulmonary embolism in the ICU[J]. Chest, 2024,166(6):1532-1545. DOI: 10.1016/j.chest.2024.04.032 .

[110]Fan E , Del Sorbo L , Goligher EC ,et al. An Official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine Clinical Practice Guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome[J]. Am J Respir Crit Care Med, 2017,195(9):1253-1263. DOI: 10.1164/rccm.201703-0548ST .

[111]Fan E , Brodie D , Slutsky AS . Acute respiratory distress syndrome: advances in diagnosis and treatment[J]. JAMA, 2018,319(7):698-710. DOI: 10.1001/jama.2017.21907 .

[112]Konstam MA , Kiernan MS , Bernstein D ,et al. Evaluation and management of right-sided heart failure: a scientific statement from the American Heart Association[J]. Circulation, 2018,137(20):e578-e622. DOI: 10.1161/CIR.0000000000000560 .

[113]Goldhaber SZ . ECMO and Surgical Embolectomy: two potent tools to manage high-risk pulmonary embolism[J]. J Am Coll Cardiol, 2020,76(8):912-915. DOI: 10.1016/j.jacc.2020.07.016 .

[114]Corsi F , Lebreton G , Bréchot N ,et al. Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation[J]. Crit Care, 2017,21(1):76. DOI: 10.1186/s13054-017-1655-8 .

[115]O′Malley TJ , Choi JH , Maynes EJ , et a l . Outcomes of extracorporeal life support for the treatment of acute massive pulmonary embolism: a systematic review[J]. Resuscitation, 2020,146:132-137. DOI: 10.1016/j.resuscitation.2019.11.018 .

[116]Goldberg JB , Giri J , Kobayashi T ,et al. Surgical management and mechanical circulatory support in high-risk pulmonary embolisms: historical context, current status, and future directions: a scientific statement from the American Heart Association[J]. Circulation, 2023,147(9):e628-e647. DOI: 10.1161/CIR.0000000000001117 .

[117]Farmakis IT , Sagoschen I , Barco S ,et al. Extracorpor eal membrane oxygenation and reperfusion strategies in high-risk pulmonary embolism hospitalizations [J]. Crit Care Med, 2024,52(10):e512-e521. DOI: 10.1097/CCM.0000000000006361 .

[118]Galiè N , Palazzini M , Manes A . Extracorporeal cardiopulmonary support in acute high-risk pulmonary embolism: still waiting for solid evidence[J]. Eur Heart J, 2018,39(47):4205-4207. DOI: 10.1093/eurheartj/ehy507 .

[119]Marti C , John G , Konstantinides S ,et al. Systemic thrombolytic therapy for acute pulmonary embolism: a systematic review and meta-analysis[J]. Eur Heart J, 2015,36(10):605-614. DOI: 10.1093/eurheartj/ehu218 .

[120]Chatterjee S , Chakraborty A , Weinberg I ,et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis[J]. JAMA, 2014,311(23):2414-2421. DOI: 10.1001/jama.2014.5990 .

[121]Meyer G , Vicaut E , Danays T ,et al. Fibrinolysis for patients with intermediate-risk pulmonary embolism[J]. N Engl J Med, 2014,370(15):1402-1411. DOI: 10.1056/NEJMoa1302097 .

[122]Wang C , Zhai Z , Yang Y ,et al. Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial[J]. Chest, 2010,137(2):254-262. DOI: 10.1378/chest.09-0765 .

[123]Li S , Gu HQ , Li H ,et al. Reteplase versus alteplase for acute ischemic stroke[J]. N Engl J Med, 2024,390(24):2264-2273. DOI: 10.1056/NEJMoa2400314 .

[124]Rashedi S , Greason CM , Sadeghipour P ,et al. Fibrinolytic agents in thromboembolic diseases: historical perspectives and approved indications[J]. Semin Thromb Hemost, 2024,50(5):773-789. DOI: 10.1055/s-0044-1781451 .

[125]Pruszczyk P , Klok FA , Kucher N ,et al. Percutaneous treatment options for acute pulmonary embolism: a clinical consensus statement by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function and the European Association of Percutaneous Cardiovascular Interventions[J]. EuroIntervention, 2022,18(8):e623-e638. DOI: 10.4244/EIJ-D-22-00246 .

[126]Ferro EG , Mackel JB , Kramer RD ,et al. Postmarketing surveillance of inferior vena cava filters among US medicare beneficiaries: the SAFE-IVC study[J]. JAMA, 2024,332(24):2091-2100. DOI: 10.1001/jama.2024.19553 .

[127]Ius F , Hoeper MM , Fegbeutel C ,et al. Extracorporeal membrane oxygenation and surgical embolectomy for high-risk pulmonary embolism[J]. Eur Respir J, 2019,53(4):1801773[pii]. DOI: 10.1183/13993003.01773-2018 .

[128]Guyatt GH , Akl EA , Crowther M ,et al. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012,141(2):Suppl-7S. 47SDOI: 10.1378/chest.1412S3 .

[129]Ageno W , Gallus AS , Wittkowsky A ,et al. Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines[J]. Chest, 2012,141(2):SupplS-e88S. e44DOI: 10.1378/chest.11-2292 .

[130]Ansell J , Hirsh J , Hylek E ,et al. Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)[J]. Chest, 2008,133(6):Suppl-160S. 198SDOI: 10.1378/chest.08-0670 .

[131]Baker RI , Coughlin PB , Gallus AS ,et al. Warfarin reversal: consensus guidelines, on behalf of the Australasian Society of Thrombosis and Haemostasis[J]. Med J Aust, 2004,181(9):492-497. DOI: 10.5694/j.1326-5377.2004.tb06407.x .

[132]Anderson JL , Horne BD , Stevens SM ,et al. Randomized tria l of genotype-guided versus standard warfarin dosing in patients initiating oral anticoagulation [J]. Circulation, 2007,116(22):2563-2570. DOI: 10.1161/CIRCULATIONAHA.107.737312 .

[133]Schulman S , Crowther MA . How I treat with anticoagulants in 2012: new and old anticoagulants, and when and how to switch[J]. Blood, 2012,119(13):3016-3023. DOI: 10.1182/blood-2011-10-378950 .

[134]Johnson JA , Gong L , Whirl-Carrillo M ,et al. Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 genotypes and warfarin dosing[J]. Clin Pharmacol Ther, 2011,90(4):625-629. DOI: 10.1038/clpt.2011.185 .

[135]Agnelli G , Buller HR , Cohen A ,et al. Oral apixaban for the treatment of acute venous thromboembolism[J]. N Engl J Med, 2013,369(9):799-808. DOI: 10.1056/NEJMoa1302507 .

[136]EINSTEIN Investigators , Bauersachs R . Oral rivaroxaban for symptomatic venous thromboembolism[J]. N Engl J Med, 2010,363(26):2499-2510. DOI: 10.1056/NEJMoa1007903 .

[137]Investigators EINSTEIN-PE , Büller HR . Oral rivaroxaban for the treatment of symptomatic pulmonary embolism[J]. N Engl J Med, 2012,366(14):1287-1297. DOI: 10.1056/NEJMoa1113572 .

[138]Schulman S , Kearon C , Kakkar AK ,et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism[J]. N Engl J Med, 2009,361(24):2342-2352. DOI: 10.1056/NEJMoa0906598 .

[139]Investigators Hokusai-VTE , Büller HR . Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism[J]. N Engl J Med, 2013,369(15):1406-1415. DOI: 10.1056/NEJMoa1306638 .

[140]Burr N , Lummis K , Sood R ,et al. Risk of gastrointestinal bleeding with direct oral anticoagulants: a systematic review and network meta-analysis[J]. Lancet Gastroenterol Hepatol, 2017,2(2):85-93. DOI: 10.1016/S2468-1253(16)30162-5 .

[141]Proietti M , Boriani G . Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal[J]. Ther Clin Risk Manag, 2018,14:1483-1488. DOI: 10.2147/TCRM.S140377 .

[142]Heo YA . Andexanet alfa: first global approval[J]. Drugs, 2018,78(10):1049-1055. DOI: 10.1007/s40265-018-0940-4 .

[143]Ruíz-Giménez N , Suárez C , González R ,et al. Predictive variables for major bleeding events in patients presenting with documented acute venous thromboembolism. Findings from the RIETE Registry[J]. Thromb Haemost, 2008,100(1):26-31. DOI: 10.1160/TH08-03-0193 .

[144]Klok FA , Kooiman J , Huisman MV ,et al. Predicting anticoagulant-related bleeding in patients with venous thromboembolism: a clinically oriented review[J]. Eur Respir J, 2015,45(1):201-210. DOI: 10.1183/09031936.00040714 .

[145]Chopard R , Piazza G , Falvo N ,et al. An original risk score to predict early major bleeding in acute pulmonary embolism: the syncope, anemia, renal dysfunction (PE-SARD) bleeding score[J]. Chest, 2021,160(5):1832-1843. DOI: 10.1016/j.chest.2021.06.048 .

[146]Couturaud F , Sanchez O , Pernod G ,et al. Six months vs extended oral anticoagulation after a first episode of pulmonary em bolism: the PADIS-PE randomized clinical trial [J]. JAMA, 2015,314(1):31-40. DOI: 10.1001/jama.2015.7046 .

[147]Rivera-Lebron B , McDaniel M , Ahrar K ,et al. Diagnosis, treatment and follow up of acute pulmonary embolism: consensus practice from the PERT consortium[J]. Clin Appl Thromb Hemost, 2019,25:1076029619853037. DOI: 10.1177/1076029619853037 .

[148]Stevens SM , Woller SC , Kreuziger LB ,et al. Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report[J]. Chest, 2021,160(6):e545-e608. DOI: 10.1016/j.chest.2021.07.055 .

[149]Jaff MR , McMurtry MS , Archer SL ,et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association[J]. Circulation, 2011,123(16):1788-1830. DOI: 10.1161/CIR.0b013e318214914f .

[150]Cuker A , Arepally GM , Chong BH ,et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia[J]. Blood Adv, 2018,2(22):3360-3392. DOI: 10.1182/bloodadvances.2018024489 .

[151]Jiménez D , Tapson V , Yusen RD ,et al. Revised paradigm for acute pulmonary embolism prognostication and treatment[J]. Am J Respir Crit Care Med, 2023,208(5):524-527. DOI: 10.1164/rccm.202212-2234VP .

[152]Sanchez O , Charles-Nelson A , Ageno W ,et al. Reduced-dose intravenous thrombolysis for acute intermediate-high-risk pulmonary embolism: rationale and design of the pulmonary embolism international thrombolysis (PEITHO)-3 trial[J]. Thromb Haemost, 2022,122(5):857-866. DOI: 10.1055/a-1653-4699 .

[153]Parunov LA , Soshitova NP , Ovanesov MV ,et al. Epidemiology of venous thromboembolism (VTE) associated with pregnancy[J]. Birth Defects Res C Embryo Today, 2015,105(3):167-184. DOI: 10.1002/bdrc.21105 .

[154]American College of Obstetricians and Gynecologists′ Committee on Practice Bulletins—Obstetrics. ACOG practice bulletin No. 196: thromboembolism in pregnancy[J]. Obstet Gynecol, 2018,132(1):e1-e17. DOI: 10.1097/AOG.0000000000002706 .

[155]Rodriguez D , Jerjes-Sanchez C , Fonseca S ,et al. Thrombolysis in massive and submassive pulmonary embolism during pregnancy and the puerperium: a systematic review[J]. J Thromb Thrombolysis, 2020,50(4):929-941. DOI: 10.1007/s11239-020-02122-7 .

[156]Blondon M , Martinez de Tejada B , Glauser F ,et al. Management of high-risk pulmonary embolism in pregnancy[J]. Thromb Res, 2021,204:57-65. DOI: 10.1016/j.thromres.2021.05.019 .

[157]Ross C , Kumar R , Pelland-Marcotte MC ,et al. Acute management of high-risk and intermediate-risk pulmonary embolism in children: a re view [J]. Chest, 2022,161(3):791-802. DOI: 10.1016/j.chest.2021.09.019 .

[158]Giustozzi M , Connors JM , Ruperez Blanco AB ,et al. Clinical characteristics and outcomes of incidental venous thromboembolism in cancer patients: Insights from the Caravaggio study[J]. J Thromb Haemost, 2021,19(11):2751-2759. DOI: 10.1111/jth.15461 .

[159]Streiff MB , Holmstrom B , Angelini D ,et al. Cancer-associated venous thromboembolic disease, Version 2.2024, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Canc Netw, 2024,22(7):483-506. DOI: 10.6004/jnccn.2024.0046 .

[160]Frere C , Farge D , Schrag D ,et al. Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials[J]. J Hematol Oncol, 2022,15(1):69. DOI: 10.1186/s13045-022-01289-1 .

[161]Yamada S , Asakura H . How We interpret thrombosis with thrombocytopenia syndrome?[J]. Int J Mol Sci, 2024,25(9):4956. DOI: 10.3390/ijms25094956 .

[162]Tufano A , Brenner B . Prevention of venous thromboembolism in medical patients with thrombocytopenia or with platelet dysfunction: the last 10 years[J]. Semin Thromb Hemost, 2024,50(1):96-103. DOI: 10.1055/s-0043-1769013 .

[163]Schramm T , Rast J , Mehic D ,et al. Fibrinolysis is impaired in patients with primary immune thrombocytopenia[J]. J Thromb Haemost, 2024,22(11):3209-3220. DOI: 10.1016/j.jtha.2024.07.034 .

[164]Carney BJ , Wang TF , Ren S ,et al. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study[J]. Blood Adv, 2021,5(24):5546-5553. DOI: 10.1182/bloodadvances.2021005966 .

[165]Khanal N , Bociek RG , Chen B ,et al. Venous thromboembolism in patients with hematologic malignancy and thrombocytopenia[J]. Am J Hematol, 2016,91(11):E468-E472. DOI: 10.1002/ajh.24526 .

[166]Andersen M Jr, Fernandez Turizo MJ , Dodge LE ,et al. Impact of thrombocytopenia on bleeding and t hrombotic outcomes in adults with cancer-associated splanchnic vein thrombosis [J]. Blood Adv, 2024,8(24):6151-6160. DOI: 10.1182/bloodadvances.2024014249 .

[167]Desciak MC , Martin DE . Perioperative pulmonary embolism: diagnosis and anesthetic management[J]. J Clin Anesth, 2011,23(2):153-165. DOI: 10.1016/j.jclinane.2010.06.011 .

[168]Oprea AD , Noto CJ , Halaszynski TM . Risk stratification, perioperative and periprocedural management of the patient receiving anticoagulant therapy[J]. J Clin Anesth, 2016,34:586-599. DOI: 10.1016/j.jclinane.2016.06.016 .

[169]Tavoly M , Wik HS , Sirnes PA ,et al. The impact of post-pulmonary embolism syndrome and its possible determinants[J]. Thromb Res, 2018,171:84-91. DOI: 10.1016/j.thromres.2018.09.048 .

[170]Luijten D , de Jong C , Ninaber MK ,et al. Post-pulmonary embolism syndrome and functional outcomes after acute pulmonary embolism[J]. Semin Thromb Hemost, 2023,49(8):848-860. DOI: 10.1055/s-0042-1749659 .

[171]Boon G , Janssen S , Barco S ,et al. Efficacy and safety of a 12-week outpatient pulmonary rehabilitation program in Post-PE syndrome[J]. Thromb Res, 2021,206:66-75. DOI: 10.1016/j.thromres.2021.08.012 .

[172]Kenny C , Lennon O , Klok FA ,et al. Effectiveness of rehabilitation programmes targeting quality of life, psychological wellbeing, and functional capacity in pulmonary embolism survivors; a systematic review and best evidence synthesis[J]. Thromb Res, 2025,246:109242. DOI: 10.1016/j.thromres.2024.109242 .

[173]Caprini JA . Thrombosis risk assessment as a guide to quality patient care[J]. Dis Mon, 2005,51(2-3):70-78. DOI: 10.1016/j.disamonth.2005.02.003 .

[174]Barbar S , Noventa F , Rossetto V ,et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score[J]. J Thromb Haemost, 2010,8(11):2450-2457. DOI: 10.1111/j.1538-7836.2010.04044.x .

[175]Djulbegovic B , Boylan A , Kolo S ,et al. Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE proph ylaxis [J]. Blood Adv, 2024,8(12):3214-3224. DOI: 10.1182/bloodadvances.2024013166 .

[176]Ortel TL , Neumann I , Ageno W ,et al. American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism[J]. Blood Adv, 2020,4(19):4693-4738. DOI: 10.1182/bloodadvances.2020001830 .

[177]Blitzer RR , Eisenstein S . Venous thromboembolism and pulmonary embolism: strategies for prevention and management[J]. Surg Clin North Am, 2021,101(5):925-938. DOI: 10.1016/j.suc.2021.06.015 .